King's College London

Research portal

Maternal serum anti-Müllerian hormone at 11-13 weeks’ gestation in the prediction of preeclampsia

Research output: Contribution to journalArticle

Cahit Birdir, Janina Fryze, Haralambos Vasiliadis, Kypros Nicolaides, Leona Poon

Original languageEnglish
Number of pages4
JournalJOURNAL OF MATERNAL FETAL AND NEONATAL MEDICINE
DOIs
Publication statusE-pub ahead of print - 2014

King's Authors

Abstract

Objective: To investigate the potential value of maternal serum anti-Müllerian hormone (AMH) at 11-13 weeks’ gestation in the prediction of preeclampsia (PE).

Methods: The serum concentration of AMH was measured at 11-13 weeks’ gestation in cases of PE (n=50) and normotensive controls (n=150). Backward stepwise multiple regression analysis was used to determine which of the factors amongst the maternal characteristics and gestation were significant predictors of the serum AMH in the control group and from the regression model the value in each case and control was expressed as a multiple of the expected median (MoM).

Results: In normotensive pregnancies, the maternal serum concentration of AMH is higher in Afro-Caribbean than in Caucasian women and in smokers than in non-smokers. In the PE group the median serum concentration of AMH was significantly higher than in the controls (2.140 ng/L, IQR 1.968-2.273, vs. 2.062 ng/L, IQR 1.938-2.181, P=0.025), but the median MoM value of AMH was not significantly different between the PE group and the controls (1.040, IQR 0.941-1.081, vs. 0.995, IQR 0.939-1.065, P=0.147).

Conclusions: Maternal serum AMH is not an effective early predictor for PE.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454